307 related articles for article (PubMed ID: 37115208)
1. Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.
Filipello F; You SF; Mirfakhar FS; Mahali S; Bollman B; Acquarone M; Korvatska O; Marsh JA; Sivaraman A; Martinez R; Cantoni C; De Feo L; Ghezzi L; Minaya MA; Renganathan A; Cashikar AG; Satoh JI; Beatty W; Iyer AK; Cella M; Raskind WH; Piccio L; Karch CM
Acta Neuropathol; 2023 Jun; 145(6):749-772. PubMed ID: 37115208
[TBL] [Abstract][Full Text] [Related]
2. Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.
Jadhav VS; Lin PBC; Pennington T; Di Prisco GV; Jannu AJ; Xu G; Moutinho M; Zhang J; Atwood BK; Puntambekar SS; Bissel SJ; Oblak AL; Landreth GE; Lamb BT
Mol Neurodegener; 2020 Oct; 15(1):62. PubMed ID: 33115519
[TBL] [Abstract][Full Text] [Related]
3. Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis.
Garcia-Reitboeck P; Phillips A; Piers TM; Villegas-Llerena C; Butler M; Mallach A; Rodrigues C; Arber CE; Heslegrave A; Zetterberg H; Neumann H; Neame S; Houlden H; Hardy J; Pocock JM
Cell Rep; 2018 Aug; 24(9):2300-2311. PubMed ID: 30157425
[TBL] [Abstract][Full Text] [Related]
4. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.
Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K
Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains.
Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Arima K
Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.
Dardiotis E; Siokas V; Pantazi E; Dardioti M; Rikos D; Xiromerisiou G; Markou A; Papadimitriou D; Speletas M; Hadjigeorgiou GM
Neurobiol Aging; 2017 May; 53():194.e13-194.e22. PubMed ID: 28214109
[TBL] [Abstract][Full Text] [Related]
7. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
Shi Q; Chang C; Saliba A; Bhat MA
J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
[TBL] [Abstract][Full Text] [Related]
8. Computational saturation mutagenesis to explore the effect of pathogenic mutations on extra-cellular domains of TREM2 associated with Alzheimer's and Nasu-Hakola disease.
Swain PS; Panda S; Pati S; Dehury B
J Mol Model; 2023 Nov; 29(11):360. PubMed ID: 37924367
[TBL] [Abstract][Full Text] [Related]
9. TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages.
Hall-Roberts H; Agarwal D; Obst J; Smith TB; Monzón-Sandoval J; Di Daniel E; Webber C; James WS; Mead E; Davis JB; Cowley SA
Alzheimers Res Ther; 2020 Nov; 12(1):151. PubMed ID: 33198789
[TBL] [Abstract][Full Text] [Related]
10. A locked immunometabolic switch underlies TREM2 R47H loss of function in human iPSC-derived microglia.
Piers TM; Cosker K; Mallach A; Johnson GT; Guerreiro R; Hardy J; Pocock JM
FASEB J; 2020 Feb; 34(2):2436-2450. PubMed ID: 31907987
[TBL] [Abstract][Full Text] [Related]
11. Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus.
Park JS; Ji IJ; An HJ; Kang MJ; Kang SW; Kim DH; Yoon SY
Traffic; 2015 May; 16(5):510-8. PubMed ID: 25615530
[TBL] [Abstract][Full Text] [Related]
12. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease.
Claes C; Danhash EP; Hasselmann J; Chadarevian JP; Shabestari SK; England WE; Lim TE; Hidalgo JLS; Spitale RC; Davtyan H; Blurton-Jones M
Mol Neurodegener; 2021 Jul; 16(1):50. PubMed ID: 34301296
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.
Piccio L; Deming Y; Del-Águila JL; Ghezzi L; Holtzman DM; Fagan AM; Fenoglio C; Galimberti D; Borroni B; Cruchaga C
Acta Neuropathol; 2016 Jun; 131(6):925-33. PubMed ID: 26754641
[TBL] [Abstract][Full Text] [Related]
14. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
[TBL] [Abstract][Full Text] [Related]
15. TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge.
Nugent AA; Lin K; van Lengerich B; Lianoglou S; Przybyla L; Davis SS; Llapashtica C; Wang J; Kim DJ; Xia D; Lucas A; Baskaran S; Haddick PCG; Lenser M; Earr TK; Shi J; Dugas JC; Andreone BJ; Logan T; Solanoy HO; Chen H; Srivastava A; Poda SB; Sanchez PE; Watts RJ; Sandmann T; Astarita G; Lewcock JW; Monroe KM; Di Paolo G
Neuron; 2020 Mar; 105(5):837-854.e9. PubMed ID: 31902528
[TBL] [Abstract][Full Text] [Related]
16. iPSC-derived microglia carrying the TREM2 R47H/+ mutation are proinflammatory and promote synapse loss.
Penney J; Ralvenius WT; Loon A; Cerit O; Dileep V; Milo B; Pao PC; Woolf H; Tsai LH
Glia; 2024 Feb; 72(2):452-469. PubMed ID: 37969043
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's Risk Gene TREM2 Determines Functional Properties of New Type of Human iPSC-Derived Microglia.
Reich M; Paris I; Ebeling M; Dahm N; Schweitzer C; Reinhardt D; Schmucki R; Prasad M; Köchl F; Leist M; Cowley SA; Zhang JD; Patsch C; Gutbier S; Britschgi M
Front Immunol; 2020; 11():617860. PubMed ID: 33613545
[TBL] [Abstract][Full Text] [Related]
18. Soluble TREM2: Innocent bystander or active player in neurological diseases?
Filipello F; Goldsbury C; You SF; Locca A; Karch CM; Piccio L
Neurobiol Dis; 2022 Apr; 165():105630. PubMed ID: 35041990
[TBL] [Abstract][Full Text] [Related]
19. Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes.
Mecca C; Giambanco I; Donato R; Arcuri C
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361745
[TBL] [Abstract][Full Text] [Related]
20. Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency.
Reifschneider A; Robinson S; van Lengerich B; Gnörich J; Logan T; Heindl S; Vogt MA; Weidinger E; Riedl L; Wind K; Zatcepin A; Pesämaa I; Haberl S; Nuscher B; Kleinberger G; Klimmt J; Götzl JK; Liesz A; Bürger K; Brendel M; Levin J; Diehl-Schmid J; Suh J; Di Paolo G; Lewcock JW; Monroe KM; Paquet D; Capell A; Haass C
EMBO J; 2022 Feb; 41(4):e109108. PubMed ID: 35019161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
